REVIVA PHARMACEUTICALS HOLDINGS, INC. RVPH
- brilaroxazine — Schizophrenia Phase 3
- brilaroxazine — Bipolar Disorder
- brilaroxazine — Major Depressive Disorder
- brilaroxazine — Attention-Deficit/Hyperactivity Disorder
nAChR α4β2 (1 companies · 4 programs)
Companies with an active program directed at nAChR α4β2.